The chimeric E2A-HLF transcription factor abrogates p53-induced apoptosis in myeloid leukemia cells

Blood

Volumn 92, Issue 4, 1998, Pages 1397-1405

  Altura, Rachel A ^b   Inukai, Takeshi ^b   Ashmun, Richard A ^b   Zambetti, Gerard P ^b   Roussel, Martine F ^b   Look, A Thomas ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 3; INTERLEUKIN 6; LEUCINE ZIPPER PROTEIN; PROTEIN BAX; PROTEIN P53; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2A HLF; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL SURVIVAL; CHIMERA; CONTROLLED STUDY; DNA DAMAGE; GAMMA IRRADIATION; GENE OVEREXPRESSION; LEUKEMIA CELL; MOUSE; MYELOID LEUKEMIA; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; TEMPERATURE DEPENDENCE; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

EID: 0032529704     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v92.4.1397.416k19_1397_1405     Document Type: Article

References (31)

1. Inaba T, Roberts WM, Shapiro LH, Jolly KW, Raimondi SC, Smith SD, Look AT: Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia. Science 257:531, 1992
2. Hunger SP, Ohyashiki K, Toyama K, Cleary ML: HLF, a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia. Genes Dev 6:1608, 1992
3. Inaba T, Inukai T, Yoshihara T, Seyschab H, Ashmun RA, Canman CE, Laken SJ, Kastan MB, Look AT: Reversal of apoptosis by the leukaemia-associated E2A-HLF chimaeric transcription factor. Nature 382:541, 1996
4. Look AT: Genes altered by chromosomal translocations in leukemias and lymphomas. in Vogelstein B, Kinzler KW (eds): The Genetic Basis of Human Cancer. New York, NY, McGraw-Hill, 1997, p 109
5. Pui C-H: Childhood leukemias. N Engl J Med 332:1618, 1995
6. Lowe SW, Bodis S, McClatchey A, Remington L, Ruley HE, Fisher DE, Housman DE, Jacks T: p53 Status and the efficacy of cancer therapy in vivo. Science 266:807, 1994
7. Hunger SP: Chromosomal translocations involving the E2A gene in acute lymphoblastic leukemia: Clinical features and molecular pathogenesis. Blood 87:1211, 1996
8. Zhou M, Yeager AM, Smith SD, Findley HW: Overexpression of the MDM2 gene by childhood acute lymphoblastic leukemia cells expressing the wild-type p53 gene. Blood 85:1608, 1995
9. Cowell IG, Skinner A. Hurst HC: Transcriptional repression by a novel member of the bZIP family of transcription factors. Mol Cell Biol 12:3070, 1992
10. Zhang W, Zhang J, Kornuc M, Kwan K, Frank R, Nimer SD: Molecular cloning and characterization of NF-IL3A, a transcriptional activator of the human interleukin-3 promoter. Mol Cell Biol 15:6055, 1995
11. Cowell IG, Hurst HC: Transcriptional repression by the human bZIP factor E4BP4: Definition of a minimal repression domain. Nucleic Acids Res 22:59, 1994
12. Ikushima S, Inukai T, Inaba T, Nimer SD, Cleveland JL, Look AT: Pivotal role for the NFIL3/E4BP4 transcription factor in interleukin 3-mediated survival of pro-B lymphocytes. Proc Natl Acad Sci USA 94:2609, 1997
13. Yonish-Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M: Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature 352:345, 1991
14. Yonish-Rouach E, Grunwald D, Wilder S, Kimchi A, May E, Lawrence JJ, May P, Oren M: p53-mediated cell death: Relationship to cell cycle control. Mol Cell Biol 13:1415, 1993
15. Muller AJ, Young JC, Pendergast AM, Pondel M, Landau NR, Littman DR, Witte ON: BCR first exon sequences specifically activate the BCR/ABL tyrosine kinase oncogene of Philadelphia chromosome-positive human leukemias. Mol Cell Biol 11:1785, 1991
16. Hirai H, Roussel MF, Kato JY, Ashmun RA, Sherr CJ: Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Methods Cell Biol 15:2672, 1995
17. Inaba T, Shapiro LH, Funabiki T, Sinclair AE, Jones BG, Ashmun RA, Look AT: DNA-binding specificity and trans-activating potential of the leukemia-associated E2A-hepatic leukemia factor fusion protein. Mol Cell Biol 14:3403, 1994
18. Mehta C: Proc-StatXact for SAS Users: Statistical Software for Exact Nonparametric Inference. Cambridge, MA, Cytel Software, 1997
19. Levine AJ: p53, the cellular gatekeeper for growth and division. Cell 88:323, 1997
20. Oltvai ZN, Milliman CL, Korsmeyer SJ: Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 74:609, 1993
21. Miyashita T, Reed JC: Tumor suppressor p53 is a direct transcriptional activator of the human bax gene. Cell 80:293, 1995
22. Lehar SM, Nacht M, Jacks T, Vater CA, Chittenden T. Guild BC: Identification and cloning of EI24, a gene induced by p53 in etoposide-treated cells. Oncogene 12:1181, 1996
23. Polyak K, Xia Y, Zweier JL, Kinzler KW, Vogelstein B: A model for p53-induced apoptosis. Nature 389:300, 1997
24. Ellis RE, Kimble J: Control of germ cell differentiation in Caenorhabditis elegans. Ciba Foundation Symposium 182:179, 1994
25. Metzstein MM, Hengartner MO, Tsung N, Ellis RE, Horvitz HR: Transcriptional regulator of programmed cell death encoded by Caenorhabditis elegans gene ces-2. Nature 382:545, 1996
26. Canman CC, Kastan MB: Role of p53 in apoptosis. Adv Pharmacol 41:429, 1997
27. Miyashita T, Krajewski S, Krajewska M, Wang HG, Lin HK, Liebermann DA, Hoffman B, Reed JC: Tumor suppressor p53 is a regulator of bcl-2 and bax gene expression in vitro and in vivo. Oncogene 9:1799, 1994
28. Zha H, Aime-Sempe C, Sato T: Proapoptotic protein Bax heterodimerizes with Bcl-2 and homodimerizes with Bax via a novel domain (BH3) distinct from BH1 and BH2. J Biol Chem 271:7440, 1996
29. Yang E, Korsmeyer SJ: Molecular thanatopsis: A discourse on the BCL2 family and cell death. Blood 88:386, 1996
30. Look AT: Oncogenic transcription factors in the human acute leukemias. Science 278:1059, 1997
31. Thompson CB: Apoptosis in the pathogenesis and treatment of disease. Science 267:1456, 1995